Kovack Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$253K Sell
1,568
-50
-3% -$8.07K 0.02% 507
2025
Q1
$275K Buy
1,618
+59
+4% +$10K 0.03% 449
2024
Q4
$259K Buy
1,559
+104
+7% +$17.3K 0.03% 501
2024
Q3
$250K Sell
1,455
-401
-22% -$69K 0.03% 487
2024
Q2
$286K Buy
+1,856
New +$286K 0.03% 431
2024
Q1
Sell
-2,156
Closed -$341K 514
2023
Q4
$341K Sell
2,156
-129
-6% -$20.4K 0.04% 390
2023
Q3
$334K Sell
2,285
-5,850
-72% -$856K 0.05% 357
2023
Q2
$1.25M Sell
8,135
-75
-0.9% -$11.5K 0.16% 133
2023
Q1
$1.27M Sell
8,210
-100
-1% -$15.5K 0.17% 133
2022
Q4
$1.28M Sell
8,310
-920
-10% -$142K 0.19% 122
2022
Q3
$1.22M Sell
9,230
-519
-5% -$68.5K 0.18% 130
2022
Q2
$1.5M Buy
9,749
+488
+5% +$75.1K 0.2% 117
2022
Q1
$1.38M Sell
9,261
-29
-0.3% -$4.32K 0.14% 154
2021
Q4
$1.51M Buy
9,290
+7,510
+422% +$1.22M 0.15% 158
2021
Q3
$296K Buy
1,780
+50
+3% +$8.32K 0.03% 536
2021
Q2
$299K Buy
1,730
+25
+1% +$4.32K 0.03% 521
2021
Q1
$274K Sell
1,705
-407
-19% -$65.4K 0.04% 498
2020
Q4
$355K Sell
2,112
-93
-4% -$15.6K 0.05% 348
2020
Q3
$347K Sell
2,205
-522
-19% -$82.1K 0.06% 300
2020
Q2
$457K Buy
2,727
+713
+35% +$119K 0.09% 225
2020
Q1
$264K Sell
2,014
-130
-6% -$17K 0.06% 320
2019
Q4
$319K Sell
2,144
-10
-0.5% -$1.49K 0.06% 344
2019
Q3
$267K Sell
2,154
-2,553
-54% -$316K 0.05% 360
2019
Q2
$663K Sell
4,707
-256
-5% -$36.1K 0.15% 161
2019
Q1
$749K Buy
4,963
+280
+6% +$42.3K 0.19% 137
2018
Q4
$582K Sell
4,683
-2,300
-33% -$286K 0.17% 145
2018
Q3
$1.11M Buy
6,983
+118
+2% +$18.7K 0.29% 91
2018
Q2
$961K Sell
6,865
-16
-0.2% -$2.24K 0.27% 94
2018
Q1
$914K Buy
6,881
+147
+2% +$19.5K 0.23% 108
2017
Q4
$839K Buy
6,734
+3,259
+94% +$406K 0.21% 117
2017
Q3
$431K Buy
+3,475
New +$431K 0.14% 170
2017
Q1
Sell
-2,591
Closed -$235K 300
2016
Q4
$235K Buy
+2,591
New +$235K 0.11% 199
2016
Q1
Sell
-1,914
Closed -$216K 235
2015
Q4
$216K Buy
+1,914
New +$216K 0.14% 175